Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase EARLY_PHASE1 3Phase 2 3Phase 4 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Lymphoid 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Multiple Myeloma 1Motor Activity 1Lymphoma 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Fatigue 1

Interventions

Cytarabine 166Cyclophosphamide 110Daunorubicin 88Methotrexate 83Etoposide 66Vincristine 63Mercaptopurine 55Rituximab 54Dexamethasone 54venetoclax 50fludarabine 47Doxorubicin 46Azacitidine 46Idarubicin 45Asparaginase 42Imatinib Mesylate 41Prednisone 39pegaspargase 37Thioguanine 36Radiotherapy 35Mitoxantrone 35Busulfan 31Peripheral Blood Stem Cell Transplantation 25Leucovorin 25Bendamustine Hydrochloride 25fludarabine phosphate 24Filgrastim 24obinutuzumab 23nilotinib 23Granulocyte Colony-Stimulating Factor 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Exercise × Other hematologic neoplasm × Clear all
NCT00884364 2009-12-23

Exercise During Chemotherapy for Patients With Hematological Malignancies

Charite University, Berlin, Germany

Phase 3 Unknown
60 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Fatigue, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Motor Activity, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡